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and USP20 could function to reverse β2AR ubiquitination and thus, 
could be involved in the regulation of receptor traf cking. Indeed, 
coexpression of the β2AR with USP33 or USP20 (USP33/20) results 
in a dramatic reduction of isoproterenol-stimulated ubiquitination 
of the receptor. In contrast, similar coexpression of catalytically 
inactive USP33/20 mutants, which retains receptor binding, does 
not lead to any decrease in receptor ubiquitination. When HEK-293 
cells expressing the β2AR are exposed to 10 m isoproterenol for 
6h, internalized β2ARs are found to colocalize with the lysosomal 
marker protein, LAMP2. Wild type USP33/20, but not the catalytically 
inactive mutants expression abolishes this colocalization. Moreover, 
in the presence of USP33/20, β2ARs are found to be redirected to 
the plasma membrane even in the continued presence of agonist 
thus inhibiting lysosomal traf cking while concomitantly promoting 
receptor recycling from the late endosomal compartments as well as 
resensitization of recycled receptors at the cell surface. Inhibition 
of both USP20 and USP33 expression by SiRNA prevents completely 
the recycling and resensitization of the receptor whereas inhibition 
of only one of the two enzymes does not. Finally, dissociation of 
constitutively bound USP20 and USP33 from the β2-AR immediately 
after agonist-stimulation and re-association upon prolonged agonist 
treatment allows receptors to  rst become ubiquitinated and then 
deubiquitinated thus providing a “trip switch” between degradative 
and recycling pathways at the late endosomal compartments. 
In conclusion, our results suggest that by de-ubiquitinating the 
internalized β2ARs, USP20 and USP33 prevent their lysosomal 
traf cking and promotes receptor recycling and resensitization to the 
plasma membrane. USP20 and USP33 thus serve as novel regulators 
that dictate both post-endocytic sorting as well as the intensity and 
extent of β2-AR signalling from the cell surface.ββ
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Cardiac automaticity, in normal conditions, is generated by the 
Sinoatrial Node (SAN) tissue.
In the last years, two pacemaker mechanisms are proposed: the 
“ion channels clock”, based on the If current and the intracellular 
SR-dependent “Ca2+ clock”, based on spontaneous diastolic Ca2+ 
release. In our opinion a relevant role is played also by the Cav1.3 
(L-type Ca2+ current) and Cav3.1 (T-type Ca2+ current) channels. 
For this reason we studied the two mouse models Cav1.3 KO and 
Cav1.3/Cav3.1 double KO in vivo and in vitro. Electrocardiograms 
analysis showed a strong bradycardia (p<0.01). Respectively the 
Heart Rate (HR) of Cav1.3 KO and Cav1.3/Cav3.1 double KO are: 
396.3 ± 39.4 bpm (N.4) and 360.9 ± 53.1 bpm (N.3); instead in 
WT the HR is 545.4 ± 29.6 bpm (N.9). In addition we detected in 
the two mouse model a marked arrhythmia determined by the 
presence of many blocks of  rst and second degree. Particularly 
Cav1.3/Cav3.1 double KO showed a dissociation of rhythm.
In vitro analysis was performed with the line scan technique on WT 
and Cav1.3 KO SAN cells to observe the dynamics of Ca2+ release. The 
results seem to indicate a difference in the frequency of transients 
that is reduced in Cav1.3 KO compared with WT. Moreover the 
transient length result to be longer in Cav1.3 KO 1248.9 ± 341.5 ms 
(N.8) than in WT 831.7 ± 259.7 ms (N.5). Interesting results are 
obtained also after the analysis of the differents parts of transient, 
as expected the recovery phase result longer in Cav1.3 KO 1053.5 ± 
313.3 ms (N.5) than in WT 553.9 ± 178.5 ms (N.8), instead the ramp 
phase result longer in WT 192.5 ± 72.18 ms (N.8) than in Cav1.3 KO 
83.25 ± 38 ms (N.5).
In conclusion our date indicate that the absence of Cav1.3 channel 
cause the slowdown of pace maker mechanism at the in vivo and in 
vitro level. More experiments are needed to draw clears conclusions 
about the role of Cav3.1 channel, but seem to be important in 
cardiac automaticity generation.
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Aim — To investigate the effects of different agonist for the 
muscarinic receptor on cardiac automaticity in Cav1.3-/-, Kir 3.4-
/- and Cav1.3-/-Kir3.4-/- mice.
Method — In vivo: mice received methoxamine or CCPA once intra-
peritoneally and telemetric recordings were run continuously 
over 8 h. Quantitative ECG analyses were performed. In vitro: 
action potentials were recorded in isolated SAN cells before and 
after application of different doses of Ach, the variation in the 
spontaneous  ring rate was evaluated.
Result — In vivo: in WT, in Cav1.3-/- and in Cav1.3-/-Kir3.4-/- mice, 
methoxamine (6 mg/kg) reduces the HR (p<0.05) of 35 %, 53 % and 
48 %, respectively, but it has not effect on Kir 3.4-/- mice. CCPA 
0.01 mg/kg and 0.05 mg/kg have not effect on HR in all the mouse 
strains tested. CCPA 0.1 mg/kg reduces (p<0.05) the HR in WT, 
Cav1.3-/- and Cav1.3-/-Kir3.4-/- of 35 %, 49 % and 46 % respectively, 
but not in Kir 3.4-/- mice.
In vitro: the pacemaker activity in WT SAN cells is strongly reduced 
with 10 nM Ach (42 %, p<0.01) and it is stopped with 50 nM Ach, but 
it is not affected using 3 nM Ach. In Cav1.3-/-Kir3.4-/- cells, Ach has 
no effect (p>0.05) at each of the three doses tested. Concerning 
Kir3.4-/- cells, we have seen a reduction (p<0.05) of the  ring rate 
both a 10 nM (18 %) and at 50 nM (25 %).
Conclusion — In vivo: Inactivation of Cav1.3 exacerbated the 
slowing of HR induced by agonists of the muscarinic signalling 
pathway in both Cav1.3-/- and Cav1.3-/-Kir3.4-/- compared to WT 
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counterparts. In contrast, inactivation of Kir3.4 channels reduced 
the responsiveness of HR to the same agonists. Thus, Kir3.4 
channels are possibly the predominant mechanism controlling HR 
under vagal input. In vitro: The spontaneous  ring rate is strongly 
reduced under Ach stimulation in SAN WT cells, but is not affected 
in Cav1.3-/-Kir3.4-/- SAN cells. Moreover, there is a small but 
signi cant reduction on  ring rate in Kir3.4-/- cells. These data 
seems to indicate Cav1.3 channels as a potential contributor in the 
muscarinic regulation of automaticity in isolated SAN cells.
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Cardiac progenitor cells of the second heart  eld (SHF) contribute to 
the poles of the elongating embryonic heart. Failure or perturbation 
of SHF development leads to congenital heart defects. Recent 
studies have demonstrated the existence, in the postnatal heart, 
of resident cardiac progenitor cells that speci cally express the 
transcription factor Islet1, a SHF marker, and that have the potential 
to differentiate into cardiomyocytes, smooth muscle and endothelial 
cells. Interestingly, several evidences suggest that these residual 
progenitor cells arise from the SHF.
Through analysis of a transgene integration site position effect we 
have identi ed the transcriptional repressor Hes1 as a novel regulator 
of SHF development. Hes1, a target gene of the Notch signaling 
pathway, is expressed SHF progenitor cells. Analysis of E15.5 Hes1-/- 
embryos reveals out ow tract alignment defects (ventricular septal 
defects and overriding aorta). At earlier developmental stages, Hes1-
/- embryos display SHF proliferation defects, cardiac neural crest 
cells reduction and fail to completely extend the out ow tract. Thus 
these data reveal a role for Hes1, and potentially Notch signaling, in 
SHF development.
Given the importance of Isl1 as a marker of resident progenitor 
cells in the later heart we are analysing the role of known and novel 
regulators of the SHF (Hes1, Fgf10 and Tbx1) in the regulation of 
myocardial progenitor cell fate and in the de nition of the critical 
niche occupied by residual cardiac progenitor cells in the forming 
and de nitive heart.
In Fgf10-/- mice, out ow tract alignment occurs normally. However, 
Fgf10-/- hearts are highly dysmorphic. We thus hypothesize that 
Fgf10 deletion may affect the proliferative capacities of SHF 
progenitors in order to maintain the residual progenitor cells pool 
in the fetal heart. Initial results have revealed that whereas Fgf10-
/- hearts undergo heart tube extension normally, proliferation is 
impaired.
Together, our results identify Hes1 as a novel regulator of SHF 
progenitor cell deployment and reveal a potential role of Fgf10 
in regulating cardiac progenitor cell fate and cardiac growth 
during the fetal period. This study will increase our understanding 
of the molecular mechanisms governing the maintenance and 
differentiation of cardiac progenitor cells.
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Notch3 code pour un récepteur transmembranaire dont l’expression 
est fortement restreinte aux cellules musculaires lisses (CML) des 
petites artères. Des études génétiques chez l’homme et la souris 
ont démontré que Notch3 était un acteur clé dans la physiologie 
normale et la pathologie des petites artères. Chez l’homme, des 
mutations dominantes de Notch3 sont responsables de la maladie 
CADASIL, une forme héréditaire de maladie des petites artères 
cérébrales. Chez la souris, Notch3 est requis pour la maturation 
postnatale des petites artères, en contrôlant l’identité artérielle et 
le remodelage du cytosquelette des CML. Notch3 joue également un 
rôle clé dans la fonction normale des petites artères, en contrôlant 
les réponses myogéniques à la pression artérielle. L’activation de 
Notch3, dans la voie canonique, induit, par clivage protéolytique, 
la libération de son domaine intracellulaire qui se lie dans le noyau 
à RBP-Jk, favorisant la formation d’un complexe activateur de la 
transcription.
Notre objectif est d’identi er et de caractériser les effecteurs de 
Notch3 dans les petites artères.
Par une approche combinant transcriptome et Q-PCR sur des 
artères de souris Notch3KO et WT, nous avons identi é 11 gènes 
candidats. Leur niveau d’expression est signi cativement diminué 
dans les artères de souris Notch3KO, à un stade où il n’existe 
pas encore de lésions cellulaires visibles, et, cette diminution est 
corrigée par la réintroduction spéci quement dans les CML d’une 
protéine Notch3WT mais pas par celle d’une protéine mutée 
défective pour la signalisation RBP-Jk. Les 6 gènes dont nous 
avons pu étudier le patron d’expression sont tous exprimés dans 
les CML artérielles. De façon remarquable, l’expression vasculaire 
est artérielle prédominante pour les 6 gènes et « petite artère » 
préférentielle pour 4 d’entre eux. De plus, chacun de ces gènes a 
un pro l d’expression unique au niveau de l’arborisation artérielle 
et capillaire, mais, la superposition des différents pro ls recouvre 
celui de Notch3.
Les travaux en cours ont pour but de déterminer si les gènes candidats 
identi és sont ou non des cibles primaires, RBPJk-dépendantes, et de 
caractériser histologiquement et fonctionnellement les mutants souris 
perte-de-fonction de ces gènes.
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We previously reported that deletion of estrogen receptor-alpha 
(ER-alpha) abolishes endothelial response to wine polyphenols. The 
present study was designed to demonstrate that delphinidin, an 
anthocyanin that possess the same pharmacological pro le than 
